'method for treating a patient suffering from metabolic disorder, method for treating at least one non-metabolic disorder in a patient, method for treating at least one metabolic disorder and at least one non-metabolic disorder in a patient method for treating at least one vascular disease in a patient and effective pharmaceutical composition for the treatment of metabolic syndrome, type 2 diabetes, obesity, or pre-diabetes '

摘要

method for treating a patient suffering from a metabolic disorder, method for treating at least one non-metabolic disorder in a patient, method for treating at least one metabolic disorder and at least one non-metabolic disorder in a patient, method for treating at least a vascular disease in a patient and an effective pharmaceutical composition for the treatment of metabolic syndrome, type 2 diabetes, obesity, or pre-diabetes. the present invention is directed to a method for treating a patient suffering from metabolic syndrome, type 2 diabetes, obesity, or pre-diabetes, comprising the step of increasing the ratio of dopaminergic neuronal activity to noradrenergic neuronal activity within the central nervous system and particularly the hypothalamus of the patient's central nervous system.